2025 年 06 月 08 日 行业周报 看好/维持 基础化工 基础化工 化工新材料周报（20250602-20250608）： 生物航煤(SAF)价格上涨，制冷剂价格维持高位 走势比较 (20%) (10%) 0% 10% 20% 30% 24/6/11 24/8/22 24/11/2 25/1/13 25/3/26 25/6/6 基础化工 沪深300 相关研究报告 <<化工周报（5/26-5/30）：三代制冷 剂价格上涨，友道化学爆炸提升农药 行业关注度>>--2025-06-03 <<化工周报（5/19-5/25）：制冷剂产 品毛利提升，H 酸带动活性染料价格 上涨 >>--2025-05-26 << 化 工 新 材 料 周 报 （ 20250519- 20250525）：制冷剂价格维持高位，炭 黑、溴素价格反弹>>--2025-05-25 证券分析师：王亮 E-MAIL：wangl@tpyzq.com 分析师登记编号：S1190522120001 证券分析师：王海涛 E-MAIL：wanght@tpyzq.com 分析师登记编号：S1190523010001 报告摘要 1.重点子行业及产品情况跟踪 ...

[Table_Message]2025-06-08 金融工程周报 $$\pm\nwarrow\pm\nwarrow\pm\nwarrow\pm\nwarrow\pm\nwarrow\pm\nwarrow\pm$$ 海内外权益市场、贵金属上涨，权益、商品基金表现较好 [Table_Author] 证券分析师：刘晓锋 电话：13401163428 E-MAIL：liuxf@tpyzq.com 执业资格证书编码：S1190522090001 研究助理：孙弋轩 电话：18910596766 E-MAIL：sunyixuan@tpyzq.com 一般证券业务登记编码：S1190123080008 内容摘要 太 平 洋 证 券 股 份 有 限 公 司 证 券 研 究 报 告 请务必阅读正文之后的免责条款部分 守正 出奇 宁静 致远 [Table_Title] [Table_Summary] . 金 融 工 程 周 报 ◼ 大类资产市场概况：1）权益：本周 A 股市场中上证指数收盘 3385.36，涨跌幅 1.13%， 深证成指、中小板指数、创业板指、上证 50、沪深 300、中证 500、中证 1000、中证 2000、 ...

Investment Rating - The industry is rated positively, with expectations of overall returns exceeding the CSI 300 index by more than 5% in the next six months [41]. Core Insights - China's defense budget has maintained a growth rate of around 7%, with defense spending accounting for less than 1.5% of GDP, which is below the average level of major military powers. There is significant room for growth in defense spending, which is expected to outpace GDP growth in the long term. The year 2025 marks the end of the "14th Five-Year Plan," and the industry is anticipated to emerge from a two-year period of stagnation, entering a phase of comprehensive recovery. As orders normalize and are gradually released, the military industry may enter a "Davis Double-Trigger" phase of performance improvement and valuation enhancement. It is recommended to focus on leading companies in advanced fighter jets, low-altitude economy, domestic large aircraft, satellite internet, and deep-sea technology, which have favorable competitive landscapes and high technological barriers [4][10]. Summary by Sections Industry Perspective - The report highlights that China's defense spending has significant growth potential, with expectations for long-term increases above GDP growth rates. The military sector is poised for recovery and improvement in performance and valuations [4][10]. Market Performance - In the past week, the CSI 300 index rose by 0.40%, while the aerospace and defense index increased by 0.18%. For the month, the CSI 300 index saw a rise of 2.74%, and the aerospace and defense index increased by 8.34% [11]. Industry News - The European Union has approved a joint venture between the UK, Italy, and Japan to develop a sixth-generation fighter jet, with plans to deliver by the end of 2035. The joint venture will serve as the main contractor and system integrator for the "Global Combat Air Programme" [3][16]. - The U.S. Defense Secretary has pressured NATO allies to increase defense spending from 2% to 5% of GDP, emphasizing the need for this change before the upcoming NATO summit [19]. - The UK has announced plans to build 12 new "SSN-AUKUS" attack submarines and invest £15 billion (approximately 146.1 billion RMB) in upgrading its nuclear facilities, aiming to enhance its military capabilities [21]. Company Tracking - Several companies are making significant moves, such as: - Shangda Co., which has been approved to establish a high-temperature and corrosion-resistant alloy materials technology center [24]. - Guorui Technology, which plans to reduce its shareholding by 3% [26]. - Northern Navigation, with plans for share reductions by its executives [27].

2025 年 06 月 05 日 行业周报 看好/维持 石油石化 石化周报（5/31-6/05）：地缘形势变化，油价有望回升 ◼ 走势比较 (20%) (12%) (4%) 4% 12% 20% 24/6/5 24/8/16 24/10/27 25/1/7 25/3/20 25/5/31 相关研究报告 <<石化周报（3/24-3/30）：国际油价 继续回升，气价格维持高位>>-- 2025-04-01 <<石化周报（3/17-3/23）：国际油价 回升，天然气价格维持高位>>-- 2025-03-24 <<海油工程（600583.SH）：24 年利润 加速增长，在手订单创新高>>-- 2025-03-23 证券分析师：白竣天 电话： E-MAIL：baijt@tpyzq.com 分析师登记编号：S1190522110001 证券分析师：王亮 电话： E-MAIL：wangl@tpyzq.com 分析师登记编号：S1190522120001 报告摘要 1.核心观点 地缘形势变化，且美国原油库存同比下降，以及美国钻机及压裂 车数量下降，油价有望回升。最新数据显示，美国商业原油库存比去 年同期下降 4.36%，美国 ...

Investment Rating - The report assigns a "Buy" rating for the company, indicating an expected relative increase of over 15% compared to the CSI 300 index in the next six months [11][12]. Core Insights - The company reported a significant Q1 performance with revenue reaching 34.998 billion yuan, a year-on-year increase of 115.65%, and a net profit attributable to shareholders of 842 million yuan, up 39.04% year-on-year [3][4]. - The company's diversified product lines, particularly in high-performance computing and smart devices, have shown remarkable growth, with data business revenue exceeding 10 billion yuan in Q1 [3][4]. - The "3+N+3" strategic upgrade has effectively established a robust platform for smart products, enhancing the company's competitive edge in the global supply chain [4]. Financial Projections - Revenue projections for 2025, 2026, and 2027 are 1389.46 billion yuan, 1682.68 billion yuan, and 2007.76 billion yuan, respectively, with year-on-year growth rates of 26.45%, 21.10%, and 19.32% [4][6]. - Net profit forecasts for the same years are 37.06 billion yuan, 45.30 billion yuan, and 57.03 billion yuan, with growth rates of 26.66%, 22.23%, and 25.89% [4][6]. - The projected PE ratios for 2025, 2026, and 2027 are 19X, 16X, and 13X, respectively [4].

Investment Rating - The investment rating for the company is "Buy" with a target price of 95.42 HKD, compared to the last closing price of 74.25 HKD [1][10]. Core Views - The report highlights that the clinical data for IBI363, a dual-specific antibody fusion protein, has exceeded expectations in treating advanced non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and melanoma [3][4][5][6]. - The company is expected to see significant revenue growth, with projected revenues of 94.22 billion HKD in 2024, increasing to 207.91 billion HKD by 2027, reflecting a growth rate of 51.82% in 2024 and 31.60% in 2027 [11][15]. Summary by Sections Company Overview - The total share capital is 1.65 billion shares, with a total market capitalization of 1,225 billion HKD [2]. - The company has a strong pipeline with multiple important developments expected in 2025, including approvals for various treatments [9]. Clinical Data - IBI363 showed a median progression-free survival (mPFS) of 9.3 months and a 12-month overall survival (OS) rate of 70.9% in patients with immune-resistant lung squamous cell carcinoma [4]. - In CRC patients, IBI363 demonstrated a median overall survival (mOS) of 16.1 months, indicating a significant improvement over existing treatment options [5]. - For melanoma, IBI363 achieved an mPFS of 5.7 months, with ongoing trials comparing it to pembrolizumab in treatment-naive patients [6]. Financial Projections - The company is projected to achieve a net profit of 6.23 billion HKD in 2025, with a significant increase to 30.77 billion HKD by 2027, reflecting a net profit growth rate of 132.26% in 2027 [11][15]. - The earnings per share (EPS) is expected to rise from -0.06 HKD in 2024 to 1.87 HKD in 2027 [11][15]. Valuation - The valuation methods used include DCF and NPV, resulting in a target market value of 1,574 billion HKD, which corresponds to the target stock price of 95.42 HKD [10].

Investment Rating - The report assigns a "Buy" rating to Tianli International Holdings (01773) with a target price based on the last closing price of HKD 4.42 [1]. Core Viewpoints - Tianli International Holdings is a leading K12 private education group in China, with a focus on high school education and diversified pathways for student advancement, supported by a stable shareholding structure and experienced management team [3][19][20]. - The company has successfully expanded its operations across 18 provinces, serving over 130,000 students, with a significant emphasis on high school education [3][18]. - The private education sector is experiencing a shift due to policy changes, with a growing demand for private high schools, which are expected to reach a market size of RMB 150 billion to 218.5 billion by 2025 [4][47]. Summary by Sections Company Overview - Tianli International Holdings has developed a comprehensive K12 education system since its establishment in 2002, evolving from a focus on K9 education to becoming a leader in the western region of China [3][13][14]. - The company has a stable shareholding structure, with the controlling shareholder holding 42.46% of the shares, ensuring effective governance and strategic execution [19][20]. Industry Status and Trends - The private education industry is undergoing regulatory changes that have led to a contraction in K9 businesses while allowing for the expansion of private high schools, which have increased from 2,585 in 2015 to 4,567 in 2023 [4][46]. - The demand for high school education continues to grow, with a current enrollment rate of 60% and a significant gap in available seats, indicating strong future growth potential [42][47]. Business Development Strategy - The company has adopted a "One Core, Multiple Supports" strategy, focusing on strengthening its high school operations while diversifying into various educational services, including online platforms and international education [4][52][56]. - The light-asset model has been implemented to reduce investment risks and costs, allowing for rapid expansion through leasing and management contracts [58][61]. Financial Analysis - The financial performance shows significant growth, with a projected revenue increase from RMB 3.32 billion in FY2024 to RMB 5.41 billion by FY2027, alongside a net profit growth from RMB 576 million to RMB 1.15 billion in the same period [5][7]. - The company is expected to maintain a stable gross margin of around 33.7% and improve its net profit margin to 16.7% [5][7].

2025 年 06 月 06 日 公司点评 买入/维持 健之佳(605266) 昨收盘:22.86 销售费用率略有提升，门店数量仍保持稳定增长 ◼ 走势比较 (60%) (44%) (28%) (12%) 4% 20% 24/6/6 24/8/17 24/10/28 25/1/8 25/3/21 25/6/1 ◼ 股票数据 | 总股本/流通(亿股) | 1.55/1.55 | | --- | --- | | 总市值/流通(亿元) | 35.33/35.33 | | 12 个月内最高/最低价 | 38.46/17.18 | | (元) | | 相关研究报告 <<省外扩张持续加速，全渠道和多元 化经营带来差异化竞争>>--2024- 02-01 <>--2022-10-29 <>--2022-08-30 证券分析师：周豫 电话： E-MAIL：zhouyua@tpyzq.com 分析师登记编号：S1190523060002 ⚫ 事件 2025 年 4 月 29 日，公司发布 2024 年年报，2024 年度公司实现营业 收入 92.83 亿元（YoY+2.23%），归母净利润 1.28 亿元（YoY-69.08% ...

Investment Rating - The report maintains a "Buy" investment rating for the company [1][7]. Core Views - The company's performance in 2024 was impacted by an increase in sales expense ratio, leading to a decline in net profit [4]. - The company achieved a revenue of 9.283 billion yuan in 2024, representing a year-on-year growth of 2.23%, while the net profit decreased by 69.08% to 128 million yuan [4][10]. - The company continues to expand its store count, reaching a total of 5,486 stores by the end of 2024, with effective membership exceeding 26 million [5][6]. Financial Performance - The company’s revenue and profit forecasts for 2025-2027 are as follows: - Revenue: 10.1 billion yuan (2025), 11.05 billion yuan (2026), 12.003 billion yuan (2027) with respective growth rates of 8.80%, 9.41%, and 8.62% [7][10]. - Net profit: 196 million yuan (2025), 242 million yuan (2026), 271 million yuan (2027) with growth rates of 53.1%, 23.3%, and 12.2% [7][10]. - The company’s gross margin for 2024 was 34.78%, a decrease of 1.10 percentage points year-on-year [4]. Market Position and Strategy - The company has a compound annual growth rate of 27.32% in the number of direct-operated pharmacies from 2019 to 2024 [6]. - The company is focusing on differentiated competition and multi-channel operations, with online channel revenue growing by 19.51% in 2024, accounting for 27.9% of total revenue [6]. - The company is actively expanding in regions such as Yunnan, Hebei, Chongqing, and Liaoning, aiming to catch up with leading pharmacy chains [6].

2025 年 06 月 05 日 行业日报 看好/维持 机械 机械 太平洋机械日报（20250605）：开普勒机器人再获新融资 ◼ 走势比较 (20%) (8%) 4% 16% 28% 40% 24/6/5 24/8/17 24/10/29 25/1/10 25/3/24 25/6/5 机械 沪深300 ◼ 子行业评级 相关研究报告 << 太平洋机械日报（20250603）：北 京人形机器人创新中心增资至 4.6 亿>>--2025-06-04 <<太平洋机械日报（20250527）：2025 第九届世界无人机大会闭幕>>-- 2025-05-28 证券分析师：崔文娟 电话：021-58502206 E-MAIL：cuiwj@tpyzq.com 分析师登记编号：S1190520020001 证券分析师：刘国清 电话：021-61372597 E-MAIL：liugq@tpyzq.com 分析师登记编号：S1190517040001 证券分析师：张凤琳 电话： E-MAIL：zhangfl@tpyzq.com 分析师登记编号：S1190523100001 [Table_Summary] 报告摘要 市场表现： 2 ...